Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1987-05-21
1989-01-17
Bond, Robert T.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514 11, 530317, 540455, A61K 3702, A61K 3142, C07K 512, C07D49814
Patent
active
047988274
ABSTRACT:
The invention provides new synergistin derivatives of formula ##STR1## in which Y is hydrogen or dimethylamino and R is a 3- or 4-quinuclidinyl radical, the isomers thereof and their mixtures, and their salts, also the preparation thereof. These compounds may be made by reaction of the corresponding 5-methylene compounds with the appropriate mercaptoquinuclidine. The products of formula (I), optionally combined with pristinamycin II.sub.A or a derivative of pristinamycin II.sub.B of the formula ##STR2## are useful as antimicrobials.
REFERENCES:
patent: 4617290 (1986-10-01), Corbet et al.
patent: 4617377 (1986-10-01), Corbet et al.
patent: 4618599 (1986-10-01), Corbet et al.
patent: 4668669 (1987-05-01), Barriere et al.
Chemical Abstracts, vol. 103, (1985), Item 160861e, Abstracting French Demande FR 2,549,065, Jan. 18, 1985.
Chemical Abstracts, vol. 103, (1985), Item 160862f, Abstracting French Demande FR 2,549,063.
Barriere Jean-Claude
Cotrel Claude
Paris Jean-Marc
Bond Robert T.
Rhone-Poulenc Sante
LandOfFree
Synergistin derivatives and pharmaceutical compositions which co does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Synergistin derivatives and pharmaceutical compositions which co, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Synergistin derivatives and pharmaceutical compositions which co will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2413593